News

As part of a promising partnership, CEPID CancerThera welcomed on May 21 a team of representatives from Amazônia Azul Tecnologias

On May 16th, the Research, Development, and Innovation Center of the Brazil-China Sociocultural Institute and the Ibrawork innovation hub (CPDI

A total of 65 abstracts of scientific papers presented at the 17th Edwaldo Camargo Symposium and the 1st CancerThera Congress,

To tackle the significant public health impact posed by cancer, the search for new diagnostic and therapeutic agents is essential.

On April 16, 2024, professors and researchers from the University of Campinas (Unicamp) and CancerThera met with representatives of the

Researchers from CancerThera welcomed Prof. Dr. Dimitris Parthimos, biomathematician and researcher at Cardiff University (United Kingdom), for a visit to

The recent meetings between the teams of CEPID CancerThera and Amazônia Azul Tecnologias de Defesa S.A. (Amazul), a company that

“Evaluation of antimicrobial, antiparasitic, and antiviral properties of silver complexes with sulfadoxine derivatives and gold N-heterocyclic carbenes” is the title

Head and neck cancer is one of the target tumors for the development of new metallodrugs and theranostics at CEPID

Prof. Dr. Edwaldo Eduardo Camargo, born on May 28, 1938, in Guaxupé (MG), was a pioneering scientist in Nuclear Medicine